The race for an Ebola therapy begins
-
By
-
O. Rose Broderick
-
Annalisa Merelli
-
Helen Branswell
-
July 6, 2026
-
Objective:
To test the effectiveness of remdesivir and MBP-134 against the Bundibugyo species of Ebola.
Approach:
- Clinical Trial: A clinical trial began in the Democratic Republic of the Congo testing remdesivir and MBP-134, both individually and in combination.
Key Findings:
- The trial aims to determine if the drugs improve survival chances for Ebola patients.
- There are substantial doses of remdesivir available, and production of MBP-134 is being ramped up in case it proves effective.
Interpretation:
The trial may take several months to yield results regarding the effectiveness of the drugs.
Limitations:
- The timeline for results could extend into next year.
Conclusion:
Sources:
